Hibiscus sabdariffa (roselle), a tropical plant rich in polyphenols, polysaccharides, organic acids, and pectins, has been extensively reviewed for its promising anti-diabetic properties. The review highlights its multifaceted benefits: it exerts hypoglycemic effects by inhibiting carbohydrate-digesting enzymes, supports pancreatic β-cell preservation and regeneration—boosting insulin secretion and improving glucose tolerance—and improves lipid metabolism while reducing oxidative stress and inflammation. Animal experiments demonstrated roselle extracts lowering fasting blood glucose, enhancing pancreatic islet health, and mitigating obesity-related dyslipidemia. In prediabetic and diabetic patients, daily consumption of hibiscus tea, drinks, or capsules significantly reduced fasting glucose and occasionally improved insulin resistance and blood pressure. Furthermore, advanced formulations, such as nanoemulsions, show potential for sustained and enhanced delivery of its bioactive compounds.
Home » Therapeutic Role of Hibiscus sabdariffa in Diabetes Management
Therapeutic Role of Hibiscus sabdariffa in Diabetes Management
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Nucleotide-Rich Meals and Uric Acid
September 29, 2026
Cumin Seed Extract and Its Wound-Healing Potential
September 29, 2026
Beetroot Juice and Heart Health After Menopause
September 21, 2026
Puerarin and the Gut–Liver–Brain Axis in Depression
September 21, 2026
Object Recognition Test (ORT): A Versatile Tool for Memory Research in Mice
September 14, 2026
Yeast Protein on Gut Barrier Function and Inflammation
September 14, 2026